Mtec-23-06-usamrdc-multi-topic-045
Active Awarded Last action
- Contract number
- HT94252390029
- Awardee
-
Medical Technology Enterprise Consortium UEI RTGVVL7F6J11
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $9,693,931
Award facts
- Contract value 82% obligated
- $11,849,153.93 Current and potential, with all options
- Completion date 72% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- Not on record
- Competition
- Competed Program Solicitation
- Pricing
- Other
- Place of performance
- Summerville, SC 29486, USA
- Primary consortia member
- Cellphire, Inc.
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $2,349,386 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $7,344,545 |
About this award
The Defense Health Agency awarded an Other Transaction Order to Medical Technology Enterprise Consortium for medical technology research and prototype development, with a ceiling value of $11.879 million and an ultimate completion date of January 18, 2028, awarded September 11, 2023.
The order was issued under MTEC-23-06-USAMRDC-MULTI-TOPIC-045 to fund administration and performance of research efforts detailed in project approval letters, including work for Cellphire Therapeutics Inc. Place of performance is Summerville, SC.
Medical Technology Enterprise Consortium operates as a nonprofit federal medical technology accelerator functioning exclusively under Other Transaction Authority with the Defense Health Agency, Army Medical Command, and Navy Bureau of Medicine and Surgery to prototype and field innovative medical solutions for military healthcare applications. The organization mobilizes academic and industry consortia partnerships—including the University of Iowa, University of Minnesota, Northwestern University, and private sector entities such as Arete Associates and Safi Biotherapeutics—to execute prototype development and experimental medical research without traditional FAR procurement constraints.
Quick answers
Who was awarded contract HT94252390029?
HT94252390029 was awarded to Medical Technology Enterprise Consortium by Defense Health Agency (Department of Defense) on September 11, 2023.
How much is contract HT94252390029 worth?
The government has obligated $9,693,931 on HT94252390029. Its current value, with exercised options, is $11,849,154.
Is contract HT94252390029 an order under another contract?
Yes. HT94252390029 is an other transaction order under W81XWH1590001, an other transaction IDV.
Was contract HT94252390029 competed?
The extent of competition for HT94252390029 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award